BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3877826)

  • 21. Comparison between agar and methylcellulose cultures of human leukemic cells.
    Kubota K; Preisler HD; Sagawa K; Minowada J
    Cancer Res; 1981 Aug; 41(8):3052-7. PubMed ID: 6941851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactivity of monoclonal anti-K 562 antibodies with cells of leukemia- and lymphoma-patients.
    Hering S; Böttger V; Baryschnikow AJ; Micheel B
    Arch Geschwulstforsch; 1985; 55(1):9-16. PubMed ID: 3885896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naphtol AS D chloroacetoesterase is associated with OKM 1 positivity in neoplastic myeloid cells.
    Delgado JE; Ballart IJ; Estevez ME; Sen L; Diez RA
    Haematologica; 1985; 70(5):451-3. PubMed ID: 3937783
    [No Abstract]   [Full Text] [Related]  

  • 24. Diversity in normal and leukemic hemopoiesis.
    McCulloch EA
    Prog Clin Biol Res; 1984; 148():59-70. PubMed ID: 6379674
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of an antigen expressed by human natural killer cells.
    Griffin JD; Hercend T; Beveridge R; Schlossman SF
    J Immunol; 1983 Jun; 130(6):2947-51. PubMed ID: 6574190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunoperoxidase method of determining the surface membrane antigens of normal and leukemic cells using Soviet-produced monoclonal antibodies].
    Gluzman DF; Nadgornaia VA; Abramenko IV; Baryshnikov AIu; Filatov AV
    Eksp Onkol; 1986; 8(6):46-9. PubMed ID: 2433122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A human myeloid cell differentiation antigen (C3H6) recognized by a murine monoclonal antibody.
    Zhang Y; Zhang LS; Xu XD
    Eur J Haematol; 1991 Apr; 46(4):250-1. PubMed ID: 2015878
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
    Ball ED; Kadushin JM; Schacter B; Fanger MW
    J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production and analysis of HH 10 monoclonal antibodies reactive to immature hematopoietic cells and their use for monitoring acute leukemia cells.
    Kato K; Naoe T; Hiraiwa A; Namikawa R; Suzuki S; Yamada K; Shiku H
    Jpn J Cancer Res; 1985 Jun; 76(6):524-31. PubMed ID: 3926583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of HLA-DR structure and a membrane-specific antigen by a granulocytopoietic line of acute leukemic blast cells].
    Palumbo A; Giovinazzo B; Marmont F; Garbarino G; Paolino F; Pegoraro L
    Boll Soc Ital Biol Sper; 1982 Mar; 58(6):271-4. PubMed ID: 6952888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells.
    Civin CI; Strauss LC; Brovall C; Fackler MJ; Schwartz JF; Shaper JH
    J Immunol; 1984 Jul; 133(1):157-65. PubMed ID: 6586833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigens common to monocytes and endothelial cells: detection by monoclonal and allospecific antibodies.
    Thompson JS; Goeken NE; Brown SA; Rhoades JR
    Prog Clin Biol Res; 1984; 149():169-87. PubMed ID: 6204337
    [No Abstract]   [Full Text] [Related]  

  • 34. Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients.
    Wahren B; Gahrton G; Hammarström S
    Cancer Res; 1980 Jun; 40(6):2039-44. PubMed ID: 6929221
    [No Abstract]   [Full Text] [Related]  

  • 35. Distribution of a new B-cell-associated surface antigen (BL7) detected by a monoclonal antibody in human leukemic disorders.
    Al-Katib A; Wang CY; Koziner B
    Cancer Res; 1985 Jul; 45(7):3058-63. PubMed ID: 3924396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
    Han T; Ozer H; Minowada J
    Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibody MCS-2 as the marker of phorbol diester-induced myeloid differentiation in acute undifferentiated leukemia.
    Gregg SL; Gajl-Peczalska KJ; LeBien TW; Bloomfield CD; Brunning R; Sagawa K
    Cancer Res; 1984 Jun; 44(6):2724-30. PubMed ID: 6372996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunodiagnosis of acute nonlymphocytic leukemia.
    Hurwitz CA; Strauss LC; Civin CI
    Immunol Ser; 1990; 53():265-87. PubMed ID: 2100559
    [No Abstract]   [Full Text] [Related]  

  • 39. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23.
    Maliszewski CR; Ball ED; Graziano RF; Fanger MW
    J Immunol; 1985 Sep; 135(3):1929-36. PubMed ID: 3894519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.